The New Normal: Machine Learning for Improved Patient Outcomes?

Events /The New Normal: Machine Learning for Improved Patient Outcomes?

Since the sudden spread of COVID-19, healthcare organizations are faced with an entirely new normal for patient diagnosis, treatment and monitoring, as well as clinical trials. What does this mean for treatment of this and other conditions?

Our panel of experts from Cancer Treatment Centers of America, everis and NTT DATA Services examine the changes as a result of the novel coronavirus, exploring the ways technology that can help us better understand science and get closer to our patients.

Here’s what you will learn:

  • How to improve patient engagement in clinical trials and increase patient enrollment
  • How AI models offer preventive, diagnostic and treatment options across a genomic landscape at a resolution and scale unimaginable just a few years ago
  • How to improve the results of existing treatments
  • How to increase quality of life for patients who need treatment throughout their lives

We’ll also highlight cancer and bipolar disorder use cases and share a recent study.



Chris Cournoyer, Board Member, CareDx

HIMSS webinar graph 


On Demand

Rob Hauser headshot

Rob Hauser

Chief Business Development and Analytics Officer

Cancer Treatment Centers of America

Ankur Parikh headhshot

Dr. Ankur Parikh

Medical Director of Precision Medicine

Cancer Treatment Centers of America

Mark Philower headhshot

Mark Philhower

Senior Director, Life Sciences

NTT DATA Services

Francisco Fernandez headhshot

Francisco Fernandez


everis Healthcare

Chris Cournoyer

Chris Cournoyer - Moderator

Board Member

CareDx and Spok Communications